← Companies
Vir Biotechnology, Inc.
Data as of Oct 16, 2026
VIR
CIK 1706431Lobbying
$350,000 in reported federal lobbying spend across 7 quarterly filings, most recently Jul 20, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.
Spend by issue
- Health Issues$300K6 filings
- Health Issues +2$50K1 filing
Latest filings, Apr 2025 onward
| Filed | Registrant and subject | Amount |
|---|---|---|
| Jul 20, 2026 | FORBES-TATE for VIR BIOTECHNOLOGY INC. Health Issues Issues related to biopharmaceutical research, development, and manufacturing for infectious disease products. | $50,000 |
| Apr 19, 2026 | FORBES-TATE for VIR BIOTECHNOLOGY INC. Health Issues Issues related to biopharmaceutical research, development, and manufacturing for infectious disease products. | $50,000 |
| Jan 17, 2026 | FORBES-TATE for VIR BIOTECHNOLOGY INC. Health Issues Issues related to biopharmaceutical research, development, and manufacturing for infectious disease products. | $50,000 |
| Oct 18, 2025 | FORBES-TATE for VIR BIOTECHNOLOGY INC. Health Issues Issues related to biopharmaceutical research, development, and manufacturing for infectious disease products. | $50,000 |
| Jul 18, 2025 | FORBES-TATE for VIR BIOTECHNOLOGY INC. Health Issues Issues related to biopharmaceutical research, development, and manufacturing for infectious disease products. | $50,000 |
| Apr 16, 2025 | FORBES-TATE for VIR BIOTECHNOLOGY INC. Health Issues Issues related to biopharmaceutical research, development, and manufacturing for infectious disease products. | $50,000 |